@article{article, title = {{Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis}}, publisher = {{American Medical Association (AMA)}}, url = {{https://eprints.whiterose.ac.uk/id/eprint/200864 }}, year = {{2023}}, month = {{5}}, author = {{Kalincik T and Sharmin S and Roos I and Freedman MS and Atkins H and Burman J and Massey J and Sutton I and Withers B and Macdonell R and Grigg A et al}}, doi = {{10.1001/jamaneurol.2023.1184}}, volume = {{80}}, journal = {{JAMA Neurology}}, issue = {{7}}, pages = {{702-713}}, note = {{Accessed on 2025/06/21}}}